FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
about
Diametrical diseases reflect evolutionary-genetic tradeoffs: Evidence from psychiatry, neurology, rheumatology, oncology and immunologyFrom genetics of inflammatory bowel disease towards mechanistic insightsTherapeutic approaches for celiac diseaseReview of statistical methodologies for the detection of parent-of-origin effects in family trio genome-wide association data with binary disease traits.Immune and genetic gardening of the intestinal microbiome.Genetically dictated change in host mucus carbohydrate landscape exerts a diet-dependent effect on the gut microbiotaGenetic architecture of vitamin B12 and folate levels uncovered applying deeply sequenced large datasets.Glucocorticoids and microbiota regulate ontogeny of intestinal fucosyltransferase 2 requisite for gut homeostasis.Faecal microbiota composition in adults is associated with the FUT2 gene determining the secretor status.Innate lymphoid cells regulate intestinal epithelial cell glycosylationFUT2 nonfunctional variant: a "missing link" between genes and environment in type 1 diabetes?Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infantsIntestinal fucose as a mediator of host-microbe symbiosis.Systems Modeling of Interactions between Mucosal Immunity and the Gut Microbiome during Clostridium difficile InfectionSecretor Status Is Strongly Associated with Microbial Alterations Observed during Pregnancy.Association of Ulcerative Colitis with FUT2 and FUT3 Polymorphisms in Patients from Southeast ChinaABO antigen and secretor statuses are not associated with gut microbiota composition in 1,500 twinsMetagenomics and personalized medicine.IL-10-producing CD4(+) T cells negatively regulate fucosylation of epithelial cells in the gutAssociation of cardiovascular and metabolic disease genes with psoriasisMothers Secretor Status Affects Development of Childrens Microbiota Composition and Function: A Pilot Study.Intestinal epithelial cells as mediators of the commensal-host immune crosstalk.2'-fucosyllactose: an abundant, genetically determined soluble glycan present in human milk.Molecular mechanisms in autoimmune type 1 diabetes: a critical review.The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation.Identification of novel risk genes associated with type 1 diabetes mellitus using a genome-wide gene-based association analysis.Blood type biochemistry and human disease.Epithelial glycosylation in gut homeostasis and inflammation.FUT2: filling the gap between genes and environment in Behçet's disease?FUT2 genetic variants as predictors of tumor development with hepatocellular carcinoma.Genome-wide association and HLA region fine-mapping studies identify susceptibility loci for multiple common infections.Association of Fucosyltransferase 2 Gene Polymorphisms with Inflammatory Bowel Disease in Patients from Southeast ChinaHuman genetic variation and the gut microbiome in disease.Human microbiota, blood group antigens, and disease.FUT2 non-secretor status is associated with Type 1 diabetes susceptibility in Japanese children.An update on vitamin B12-related gene polymorphisms and B12 status.Characterisation of rapid progressors to type 1 diabetes among children with HLA-conferred disease susceptibility.Application study of 1,2-α-l-fucosynthase: introduction of Fucα1-2Gal disaccharide structures on N-glycan, ganglioside, and xyloglucan oligosaccharide.Medical relevance of protein-truncating variants across 337,205 individuals in the UK Biobank study.Introduction of H-antigens into oligosaccharides and sugar chains of glycoproteins using highly efficient 1,2-α-l-fucosynthase.
P2860
Q26782139-D7AF3CE2-1C7C-4FA6-881A-6CCC6C3BBB3CQ26824328-38A765E0-5017-446A-A285-0A13413B975BQ26825413-EDADE1C7-8C5E-48FE-9425-498A0A7866B4Q30829290-7852789B-5C95-4272-AFAE-491E8FFE2642Q34143465-A8C5606C-ECE2-4B63-8A98-426F623479C1Q34372980-62CA6AC0-29B3-4A7B-85EA-0DEF8EF33306Q34765381-F8D89E9D-B763-4D6C-9667-572E471A3675Q34866909-E124D4B6-789B-4319-AE01-2561BA0BB89BQ35147973-9E6B640E-BE97-4BE5-B212-15A4106B2F66Q35249518-F25667A8-457B-4B45-8655-3C44A2763408Q35405602-51E4385D-FCE6-4655-A199-36D8C673375AQ35545529-59F3E63C-DE8B-42FB-9C8A-F051D14143C9Q35655273-F5A73F2A-4EDE-4657-8B8A-515E47CA3759Q35729663-9D060E45-CB86-4E9B-B9FF-04168F1B2CF3Q35731477-BAFCD623-BB08-449D-9C15-6D4F20E163E6Q35894200-87C0AF2A-B9CF-4443-AD79-E68418D81A77Q36200072-924F6E1F-5B73-475D-AA96-2B712819DA68Q36202077-983E00D0-AC1A-4603-9091-6E35F4E5326AQ36237672-31326097-9695-4CFC-8C8E-C1AD4BCC9BE8Q36605296-9C048988-7837-4FD3-99E5-95A2AC768F8CQ37265618-9F022957-E9A3-4F0C-B8DC-1130BEF750FBQ37671432-6917A822-8448-46F8-BE42-FB91E788123DQ38163608-435493E5-CB35-44B9-8888-80B9FFDE5E12Q38206114-02BA4324-8BF4-4355-BE17-792A1A4B1969Q38302847-48D59EF8-F3AB-4E45-B755-8902A6CC6F12Q38470136-2D6C38DF-F3A1-49F6-8985-5DADCA933236Q38947495-9E34059F-AF55-4C39-B3D9-05BD76AA2BD9Q38985455-B955B9D8-522B-45F3-BAD7-F471BF703C48Q39606833-6E0E06AE-1EC0-4A20-9F5E-B465DBA200F2Q41455314-696F8698-9A83-4027-B1C5-569E7646D2D4Q41701124-BB08B8C8-D657-40CF-93F6-CAC8DAC95F6AQ42327964-A8767C12-8922-44FA-B31E-A252C7BA11D5Q46318762-6AE3987C-3277-4168-A326-1BE884A58B6CQ47874427-36071F65-3EEA-440F-A9F6-D85D7D27E3AAQ50223722-876CCDF0-74F4-4802-9E97-A5BBD1B89581Q50256416-1E66A683-BBC1-432A-A1B6-BD501C329625Q50760046-FFBED799-ABA1-426C-A1CB-6E113219E91DQ51102817-FC30962D-5C04-47E5-AD35-32CF2422AE89Q52310633-C0989587-D6E2-4C12-B3FB-DF31D307CE72Q54276249-518BD951-DEB7-4AA5-995B-3EBF0E13EF6E
P2860
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
@ast
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
@en
type
label
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
@ast
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
@en
prefLabel
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
@ast
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
@en
P2093
P2860
P50
P356
P1433
P1476
FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection
@en
P2093
Helen Stevens
Jason D Cooper
Kate Downes
Pamela Clarke
Trupti Mistry
P2860
P304
P356
10.2337/DB11-0638
P407
P577
2011-11-01T00:00:00Z